Seminars in Oncology Nursing
Volume 22, Issue 3 , Pages 144-151 , August 2006

Chemotherapy and Cutaneous Toxicities: Implications for Oncology Nurses

  • Pamela Hallquist Viale

      Affiliations

    • Corresponding Author InformationAddress correspondence to Pamela Hallequist Viale, RN, MS, CS, ANP, AOCNP, 12721 Star Ridge Court, Saratoga, CA 95070-6510

References 

  1. Alley E , Green R , Schuchter L . Cutaneous toxicities of cancer therapy . Curr Opin Oncol . 2002;14:212–216
  2. Leo S , Taveri R , Campanella GA , et al.  Dermatological toxicity from chemotherapy containing 5-fluorouracil . J Chemother . 1994;6:423–426
  3. Guillot B , Bessis D , Dereure O . Mucocutaneous side effects of antineoplastic chemotherapy . Expert Opin Drug Safety . 2004;3:579–587
  4. Fawcett RS , Linford S , Stulberg DL . Nail abnormalities (Clues to systemic disease) . Am Fam Physician . 2004;69:1417–1424
  5. Minisini AM , Tosit A , Sobrero AF , et al.  Taxane-induced nail changes (Incidence, clinical presentation and outcome) . Ann Oncol . 2003;14:333–337
  6. Marrs J , Newton S . Chemotherapy-induced nail changes (An unsightly nuisance) . Clin J Oncol Nurs . 2004;8:527–528
  7. Monti M , Mancini LL , Ferrari B , et al.  Case 2 (Cutaneous toxicity induced by cetuximab) . J Clin Oncol . 2003;21:4651–4652
  8. Robert C , Soria J , Spatz A , et al.  Cutaneous side-effects of kinase inhibitors and blocking antibodies . Lancet Oncol . 2005;6:491–500
  9. Hussain S , Anderson D , Salvatti ME , et al.  Onycholysis as a complication of systemic chemotherapy . Cancer . 2000;88:2367–2371
  10. Scotte F , Tourani J , Banu E , et al.  Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand . J Clin Oncol . 2005;23:4424–4429
  11. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0. Rockville, MD, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. June 10, 2003.
  12. Agterof MJ , Biesma DH . Bortezomib-induced skin lesions . N Engl J Med . 2005;352:2534
  13. Polovich M , White JM , Kelleher LO . Chemotherapy and Biotherapy Guidelines and Recommendations for Practice . Ed 2. Pittsburgh, PA: Oncology Nursing Society; 2005;
  14. Cohen AD , Mermershtain W , Geffen DB , et al.  Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins . J Derm Treat . 2005;16:19–21
  15. Wilkes JM , Doyle D . Palmar-plantar erythrodysesthesia . Clin J Oncol Nurs . 2005;9:103–106
  16. Lin EH , Morris J , Chau NK , et al.  Celecoxib attenuated capecitabine induced hand and foot syndrome (HFS) and diarrhea and improved time to tumor progression in metastatic colorectal cancer . Proc Am Soc Clin Oncol . 2002;21:138b; [abstr 2364]
  17. Eich D , Scharffetter-Kochanek K , Eich H , et al.  Acral erythrodysesthesia caused by intravenous infusion of docetaxel in breast cancer . Am J Clin Oncol . 2002;25:599–602
  18. Demircay Z , Gurbuz O , Alpdog RB , et al.  Chemotherapy-induced acral erythema in leukemic patients (A report of 15 cases) . Int J Dermatol . 1997;36:593–598
  19. Millot F , Auriol F , Brecheteau P , et al.  Acral erythema in children receiving high-dose methotrexate . Pediatr Dermatol . 1999;16:398–400
  20. Gobel BH . Chemotherapy-induced hypersensitivity reactions . Oncol Nurs Forum . 2005;32:1027–1035
  21. Gonzalez ID , Saez RS , Rodilla RS , et al.  Hypersensitivity reactions to chemotherapy drugs . Alergol Immunol Clin . 2000;15:161–181
  22. Apisarnthanarax N , Duvic M . Dermatologic complications of cancer chemotherapy . In:  Bast RC ,  Kufe DW ,  RE Pollock , et al. editor. Cancer Medicine . Ed 5. Hamilton, Ontario: Decker; 2000; Available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=cmed.chapter.38915. (accessed June 8, 2006).
  23. Schulmeister L , Camp-Sorrell D . Chemotherapy extravasation from implanted ports . Oncol Nurs Forum . 2000;27:531–538
  24. Mandanas RA. Graft versus host disease: E Medicine. Available at: http://www.emedicine.com/med/topic926.htm. (accessed June 8, 2006).
  25. O’Rourke ME , High K . Diagnosing graft versus host disease . Clin J Oncol Nurs . 2000;4:47–48
  26. Perez-Soler R , Delord JP , Halpern A , et al.  HER1/EGFR inhibitor-associated rash (Future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum) . Oncologist . 2005;10:345–356

PII: S0749-2081(06)00061-1

doi: 10.1016/j.soncn.2006.04.007

Seminars in Oncology Nursing
Volume 22, Issue 3 , Pages 144-151 , August 2006

Article Tools

* Image Usage & Resolution